Chargement en cours...
High-Risk, Clinically Localized Prostate Cancer: Is Monotherapy Adequate?
High-risk, clinically localized prostate cancer represents a diverse disease entity. Patients who are considered to be at highest risk for biochemical failure after localized treatments may not be at significant risk for disea-sespecific mortality. In this review, an attempt will be made to define h...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MedReviews, LLC
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1887814/ https://ncbi.nlm.nih.gov/pubmed/17554402 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|